Efficacy and related factors of camrelizumab combined with lenvatinibin first-line treatment of unresectable liver cancer
SHI Ning
CHEN Zhi-hong
LI Qiao
Machine-generated Keywords：
Publication Date：2022-11-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：8( 1286-1293 )